Navigation Links
AbGenomics International, Inc. Regains Global Rights to AbGn-168H from Boehringer Ingelheim
Date:12/16/2011

LOS ALTOS, Calif., Dec. 16, 2011 /PRNewswire-iReach/ -- AbGenomics International, Inc. today announced that, effective February 13, 2012, it will regain global rights to AbGn-168H, a humanized monoclonal antibody against CD-162, as part of an agreed–upon arrangement following the termination of its collaboration with Boehringer Ingelheim, Germany. AbGn-168H preferentially induces apoptosis of late-stage activated T-cells and is being developed for the treatment of psoriasis and other immunological diseases.

(Photo: http://photos.prnewswire.com/prnh/20111216/CG24413)

Data are available from two phase one clinical trials under this development program. AbGenomics plans to continue the development of AbGn-168H in psoriasis as well as in other immune and inflammatory disease indications and will therefore seek a new partner. 

"AbGenomics has had an excellent collaboration with Boehringer Ingelheim since 2005," said Dr. Rong-Hwa Lin, founder and CEO of AbGenomics. We greatly appreciate the many contributions of the Boehringer Ingelheim team particularly with respect to its development and manufacture of the drug substance and drug product as well as advancing the program into the clinical trial stage. We also appreciate their support during this transition period as we continue the preparations for the next clinical trial."

"We believe that the unique mechanism of action of AbGn-168H is applicable to a wide variety of immunological diseases," said Dr. Lin. "While we will continue to develop AbGn-168H for psoriasis, regaining the global rights will also permit us to consider other indications that will take advantage of the full therapeutic potential of this drug."

About AbGenomics (www.abgenomics.com)

AbGenomics is a biopharmaceut
'/>"/>

SOURCE AbGenomics International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. Arno Therapeutics, Inc. Completes $18 Million Financing and Reverse Merger with Laurier International, Inc.
2. Medizone International, Inc. (MZEI.PK): Trials of the AsepticSure Hospital Sterilization System Have Begun
3. Chindex International, Inc. to Report Second Quarter Fiscal 2010 Financial Results
4. Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results
5. Natural Alternatives International, Inc. Announces Filing of Patent Infringement Lawsuit
6. DATATRAK International, Inc. Announces Year-End Backlog
7. New Database from ANSI, AAMI, ASTM International, and DIN Provides Centralized Source of Information for Medical Device Professionals
8. DAVISCO Foods International, Inc. and MEGGLE Group Announce a Joint Venture for the Production of Pharmaceutical Lactose.
9. Lexington International, LLC Receives 2009 U.S. Presidents E Award Recognizing its Export Achievements
10. International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia
11. International Growth Continues: Rhythmlink International, LLC Receives CE Marking & ISO 13485 Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013 /PRNewswire-iReach/ -- Today leading ... all new data ranking Pharmaceutical web sites for usability, ... Sciences, User Experience Cloud platform, which compares how people ... on the web. The top three performers ... convert people overall. The bottom performers have usability problems, ...
(Date:6/19/2013)... 19, 2013 /PRNewswire-iReach/ -- In its first ... pharmaceutical company dedicated to advancing development of ... sustained release drug therapies in patient disease ... announced the acquisition of Enzon Pharmaceutical,s PEGylation ... associated product pipeline. Acquisition of this technology ...
(Date:6/19/2013)... 19, 2013  Omnicell, Inc. (NASDAQ: ... supply management solutions and analytics software for healthcare ... number one overall pharmacy equipment vendor in the ... a leading independent healthcare research firm, compared the ... its annual rankings. Omnicell also received the prestigious ...
Breaking Medicine Technology:Sunovion tops new Change Sciences User Experience Rankings for Pharmaceutical Industry while McNeil-PPC ranks worst overall 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 2Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 3Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 4
...   Unigene Laboratories, Inc. (OTCBB: UGNE), ... of peptide-based therapeutics, announced that Ashleigh Palmer, President and ... the Biotech Showcase™ 2012 in San Francisco, CA on ... p.m. ET).  Mr. Palmer,s presentation will include an overview of ...
... Md., Jan. 4, 2012 /PRNewswire-iReach/ -- ... pharmaceutical company focused exclusively in the HIV-1 therapeutic ... to provide medicinal chemistry services to support DFH ... maturation inhibitor drugs. Maturation inhibitors are a novel ...
Cached Medicine Technology:Unigene to Present at Biotech Showcase™ 2012 in San Francisco on January 9 2DFH Pharma to Collaborate with CiVentiChem to Develop Second-Generation HIV Maturation Inhibitor Drugs 2DFH Pharma to Collaborate with CiVentiChem to Develop Second-Generation HIV Maturation Inhibitor Drugs 3
(Date:6/19/2013)... 2013 McGuff Pharmaceuticals, Inc. ... Drug Application (ANDA) for Hydroxyprogesterone Caproate Injection, USP 250mg/mL, ... Squibb’s drug fomerly known as Delalutin™. We are ... the anticipated approval and market introduction dates for McGuff’s ... status of our pending ANDA, to date, McGuff has ...
(Date:6/19/2013)... Calculating insurance rates is a complex process that ... and of course their own company policies. This process ... from company to company, and why by shopping around for ... often save, as car insurance can be a hefty expense ... the top factors that determine their car insurance premiums. ...
(Date:6/19/2013)... June 19, 2013 Sudden cardiac arrest can ... sets in an average of 5 minutes after cardiac arrest, ... 11 minutes. This means that death is highly probable if ... readily available for use. In response to this dire reality, ... to Save Lives Act (H.R. 2308) which would provide support ...
(Date:6/19/2013)... June 19, 2013 Anant Goel, CEO at ... changing rapidly. The first industrial revolution began in Britain in ... industry… when the factory was born. The second industrial revolution ... the moving assembly line and ushered in the age of ... the 21st century. Manufacturing is going digital and this could ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Indosoft ... Center ACD for Asterisk, announced today the ... 5.7. This enhancement offers improved options for extracting, ... dashboards for effective contact center management. , Large ... real-time captured as it happens from the call ...
Breaking Medicine News(10 mins):Health News:Current Progress Towards ANDA Approval of Hydroxyprogesterone Caproate Injection, USP 2Health News:icandrive.ca Provides Tips to Understand the Top Factors That Affect Car Insurance Premiums 2Health News:icandrive.ca Provides Tips to Understand the Top Factors That Affect Car Insurance Premiums 3Health News:AED.com Supports Automated External Defibrillator (AED) Legislation in Schools in US and UK 2Health News:RKNet Studios Announced Cognitions Bridge Intelligence Games for Fun, Cognitive Skills Testing and Development for Success in Life 2Health News:RKNet Studios Announced Cognitions Bridge Intelligence Games for Fun, Cognitive Skills Testing and Development for Success in Life 3Health News:RKNet Studios Announced Cognitions Bridge Intelligence Games for Fun, Cognitive Skills Testing and Development for Success in Life 4Health News:Indosoft Improves Q-Suite Real-time ACD Reporting to Enhance Contact Center Productivity 2
... for foreign markets and plans,Canadian rollout, ... (OTC,Bulletin Board: UKMA), a lifestyle multimedia and ... personal development, announced today that,its exclusive international ... Xflowsion DVD series at the Electronic,Retailer,s Association ...
... Determinations, WASHINGTON, Oct. 28 National ... Administration,s,new "Compassionate Allowances Process" for disability determinations, ... Before announcing this,proposal, Social Security held public ... information from experts. NPAF, in collaboration with ...
... could reduce the cost and time required for cancer ... 28 online issue of the Journal of the ... a multistep process that involves in vitro tests, animal ... Inadequately designed rodent studies have led to missteps and ...
... DURHAM, N.C. -- Popular cholesterol-busting drugs -- statins -- appear ... according to researchers in the Duke Prostate Center and the ... prevent prostate cancer growth or just mask it is not ... statins were less likely to develop advanced forms of prostate ...
... become a billion-dollar substitute for flying business people ... to make sound judgments about speakers being viewed ... in a journal of the Institute for Operations ... in the Field: A Heuristic Processing Model" is ...
... because it may worsen another is a treatment trade-off ... rather take part in, researchers at Yale School of ... Journal of the American Geriatrics Society . , ... least two chronic conditions, and 24 percent have four ...
Cached Medicine News:Health News:uKarma Reports Progress With International Distribution Agreement for Its Xflowsion DVD Series 2Health News:National Patient Advocate Foundation (NPAF) Commends SSA's New 'Compassionate Allowances Process' 2Health News:Cholesterol-lowering drugs may also lower PSA, but whether they cut cancer risk is still not known 2Health News:Videoconferencing more confusing for decision-makers than face-to-face meetings 2Health News:Elderly fare better when included in decisions on treatment trade-offs 2
Fenestrated 14 mm blades. Wide extension of blade for protection of lids. Self-locking mechanism. Dull finish....
Solid 16 mm blades. Self-locking mechanism. Dull finish....
Infant model. Blades: 7 mm. Solid blades with locking mechanism. Dull finish....
Fenestrated 16 mm blades. Self-locking mechanism. Dull finish....
Medicine Products: